Together, these results support that abnormal lipid metabolism results in accumulated bile acids, which activate FXR pathways and promote the process of borderline NASH progressing to NASH (8th to 16th week), and oxidative damage occurs in this period. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.